Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perfluorocarbon emulsions are synthetic, biochemically inert, halogenated-carbon liquids formed into emulsions for intravenous administration, designed to transport and deliver oxygen to tissues in situations of hypoxia, ischemia, or where blood substitutes are needed. Owing to their high oxygen solubility, these emulsions can carry and release oxygen by simple diffusion, independent of hemoglobin. Clinically, several PFC emulsions (e.g., Fluosol-DA, Perftoran, Oxygent) have been studied or used as blood substitutes, anti-ischemic agents, or imaging contrast medias, but none is a molecular target for small-molecule or biologic agents. Instead, they function as a therapeutic delivery system rather than a biological target.
Mechanically dissolve and carry large quantities of oxygen; upon injection, PFC droplets absorb oxygen in the lungs, transport it through the circulation, and release it into hypoxic tissues via diffusion gradients
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perfluorocarbon emulsion (oxygen carrier) (PFC emulsion).